Data from a third planned interim analysis of a phase III trial are consistent with earlier results supporting the efficacy and safety of abiraterone acetate (Zytiga) as a treatment for chemotherapy-naïve men with metastatic castration-resistant prostate cancer.
Three urologists discuss how they review prostate cancer treatment options with their patients.
The new-generation GreenLight XPS-180W laser system (American Medical Systems, Minnetonka, MN) achieved an improved rate of tissue vaporization and overall efficacy in patients with BPH compared to an earlier generation laser, according to results of a recent multicenter study.
Urethral stricture is a morbid disorder for many patients, and old age and greater stricture length are associated with a particularly high risk of complications, Canadian researchers report.
Despite their apparent complexity, trusts can be extremely useful in many aspects of planning your estate.
Robot-assisted laparoscopic prostatectomy in patients with intermediate- or high-risk cancers achieves outcomes similar to those seen with the open procedure, say researchers from Vanderbilt University, Nashville, TN.
In this case, the woman claimed her damages from the negligent nerve injury included pain and weakness in her legs and a second operation to replace the sling.
The way medical necessity is currently being reviewed and judged is cause for concern.
The clinical advantages of adjuvant or salvage radiation therapy in patients treated for prostate cancer by radical prostatectomy is currently a much-debated issue and is frequently decided for the individual patient. New evidence, however, seems to indicate that secondary radiation therapy (RT) does not negatively affect urinary continence.
Compensation is a big reason that specialists are joining the ranks of the hospital employed. But there are many factors beyond compensation to consider in hospital employment.
Initial success rates of abdominal sacrocolpopexy for pelvic organ prolapse decline over the long term, according to a recently published multicenter study.
A new study has confirmed that a genetic test that measures cell cycle progression (CCP) can be a useful tool for predicting which patients will have prostate cancer recurrence, especially when combined with existing information from laboratory and pathology tests.
The FDA has approved radium Ra 223 dichloride (Xofigo) injection for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases, and no known visceral metastatic disease.
Older prostate cancer patients with three or more underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by UCLA urologists.
The push to reform Medicare’s sustainable growth rate (SGR) formula continues in Washington, with support for SGR repeal coming from leading House of Representatives committees.
Saying it’s time to take the guesswork out of buying a legitimate drug online and combat counterfeiters, Pfizer has launched a prescription-fulfillment website for the phosphodiesterase type-5 inhibitor sildenafil citrate (Viagra).
The AUA and the American Society for Radiation Oncology (ASTRO) have released a joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.
A new genomic test for prostate cancer appears to help predict whether men are more likely to harbor an aggressive form of the disease, report researchers from the University of California, San Francisco.
Urologists’ compensation for on call coverage compares favorably with that of some other specialties and exceeds family physicians’ compensation, according to a survey that shows a wide variation in on call compensation by specialty.
Pediatric urology surgeon David Roth, MD, has been named the chief of urology at Texas Children’s Hospital in Houston.
Data from a recent multicenter study provide new evidence that the beta-3 adrenoceptor agonist mirabegron (Myrbetriq) appears to be a viable alternative in patients with overactive bladder (OAB) who are poor responders to antimuscarinic agents or intolerant of their adverse events.
Trigonal onabotulinumtoxinA (Botox) brings equal analgesic relief to patients with ulcerative and non-ulcerative forms of bladder pain syndrome/interstitial cystitis (BPS/IC) alike, researchers say.
New evidence from the European Randomized Study of Screening for Prostate Cancer (ERSPC) suggests that prostate cancer screening is beneficial, particularly in the core age group of 55 to 69 years.
Men with symptomatic BPH had statistically significant, durable improvement in lower urinary tract symptoms (LUTS) following an office-based, minimally invasive prostatic urethral lift procedure, results of a pivotal randomized trial showed.
Building on previous research suggesting a cause-and-effect link between mental illness and urinary dysfunction, a new study finds that older men with two or more lower urinary tract symptoms are more likely to have recently had thoughts of suicide.
Wake Forest University researchers have conducted early, pre-clinical work that they say supports further research on the use of spermatogonial stem cell (SSC) transplantation as a potential treatment for male infertility.
Stress incontinent women whose urinary urgency incontinence worsens following a sling procedure are a heterogeneous group, researchers report.
Robot-assisted laparoscopic prostatectomy in patients with intermediate- or high-risk cancers achieves outcomes similar to those attained by the open procedure, results of a large retrospective comparative study indicate.
Urologists and engineers have developed an instrument that may improve the adjustment capabilities of a magnetic coupling system used in laparoscopic procedures.
Following the rollout of several new treatments for metastatic, castration-resistant prostate cancer (mCRPC), a new AUA clinical guideline is aimed at assisting in clinical decision making.